Randolph Company’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Randolph Company's DGX Position: Q2 2020 in Review
Randolph Company sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 202,207 shares — an estimated $16.2M sold.
Randolph Company first reported a position in DGX in Q4 2013 and held it in 15 quarters. The position peaked at $23M in Q1 2017. 749 funds tracked by Wall St. Rank hold DGX as of Q2 2020.
- Randolph Company reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
- Randolph Company sold 202,207 Quest Diagnostics shares in Q2 2020, an estimated $16.2M.
- Randolph Company first reported a position in Quest Diagnostics in Q4 2013 and held it in 15 quarters.
- Randolph Company's Quest Diagnostics position peaked at $23M in Q1 2017.
- 749 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.
Based on Randolph Company's 13F filing for Q2 2020, filed 22 Jul 2020.